ReviewExpert opinion on drug discovery2026
Combining cutting edge computational and experimental methods for targeting KRAS mutations in non-small cell lung cancer.
Ram Samudrala et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.